Peter Hoskin is supported by the NIHR Manchester Biomedical Research Centre.
The management of metastatic bladder cancer is palliative.Best outcomes are achieved in those who are fit enough for systemic therapies.The place of radiotherapy in these patients is mainly for symptom control,in part...